ABIOMED CLOSES OFFERING OF 2.42M SHARES AT $17.38 EACH -
Abiomed Climbs On Increased Volume -
ABIOMED TO OFFER 2.42M SHARES TO THE PUBLIC -
ABMD: Q1 Earnings Call @ 08:30 ET Today [delayed] -
Abiomed Announces 16% Revenue Growth to $16.4 Million for First Quarter of Fiscal 2009 -
ABMD touches 50-day moving average at 18.93 -
Abiomed First Fiscal Quarter 2009 Earnings and Conference Call Notification -
Abiomed Announces Impella 2.5 Capacity Expansion Plans in Ireland -
Abiomed Closes At Multi-Year High -
Abiomed Hits New High In Early Trading -
Abiomed Sets Multi-Year High On FDA Approval -
FDA Approves Abiomed's Impella 2.5 To Maintain Blood Flow In Heart Failure Patients -
Abiomed Hits Highest Level In Over Three Years On FDA Approval -
ABIOMED JUMPS 15%; GETS FDA OK FOR IMPELLA 2.5 CARDIAC ASSIST DEVICE -
Abiomed Hits Multi-Year High -
ABMD: Receives 510(k) Clearance from FDA for Impella 2.5 Device -
ABIOMED GETS FDA 510(K) CLEARANCE FOR IMPELLA 2.5 DEVICE -
Abiomed Inc (ABMD) Corporate Event Announcement Notice -